Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-10-01 07:40:51 - browse：547

Silhouette of a person with short hair taking a sip of red wine in a winery — coverage from STAT — MARCO BERTORELLO/AFP via Getty Images

In 1995, when Marion Nestle was on the committee drafting the Dietary Guidelines for Americans, things were run differently. She and other experts handled it all: deciding on nutrition-related research questions, collecting the evidence, issuing a scientific report, and then writing guidance for how Americans should eat.

When it came time for that last part — the writing — Nestle and two co-authors got together at a bar, ordered glasses of wine, and got to work. “I’m not kidding,” she said. At the time, the research suggested small amounts of alcohol reduced the risk of heart disease. The guidelines reflected that. “Alcoholic beverages have been used to enhance the enjoyment of meals by many societies throughout human history,” read a part of the 1995 document (a note Nestle says was added last-minute by a federal official who believed in wine’s benefits).

The issue of alcohol — and how much of it Americans should consume — is up for debate again as the dietary guidelines undergo updates and revisions, due in 2025. Already, there’s simmering debate over a growing body of research, plus clashing of interests and the same specter of controversy that’s followed the report since Nestle’s time.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Duchenne patients, backed by ‘dark money’ group, to debate drug prices

WSS

Bring on the sabbaticals for nurses

Mirador, a new biotech startup, launches with $400 million

'Patient friction coefficient' can gauge a clinical trial's patient burden

Pfizer's Covid pill remains 89% effective in final analysis, company says

Did the public have the right to know Arthur Ashe had AIDS?

New case study details death in closely watched Alzhiemer's trial

explore

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

Bright Health sells Medicare Advantage business to Molina

CRISPR technology availability, affordability needs to be expanded

ChatGPT in medicine: STAT answers readers' burning questions

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

State Dept. review finds Biden bears some blame for Afghanistan failures

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

How to save PrEP access — and even expand it

U.K. officials, researchers try to ease path for bespoke genetic treatments

Heart attack and stroke risk calculators need revising

7 people shot in DC, police say

explore

Pfizer, Moderna say biotech, pharma drug development is a sprint

Asbestos ban is immediate, but health effects will linger for decades

Mirador, a new biotech startup, launches with $400 million

7 people shot in DC, police say

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Mirador, a new biotech startup, launches with $400 million

focus

entertainment

focus

entertainment